Dr. Andreas Leiherer is Co-Chair of Basic and Molecular Research, and Associate Professor within the Molecular Biology Laboratory at the Vorarlberg Institute for Vascular Investigation (VIVIT) , Austria.
His research interests include Molecular Biology, Diabetes, Atherosclerosis, Insulin Resistance, HIV, Metabolism, Infection, Metabolic Diseases, and Nutrition.
My research aims at understanding the eco-evolutionary pathways that lead to emergence and dispersal of zoonotic and human pathogens, with emphasis on land use and climate change, within the One Health approach. I employ genomics, metagenomics and phylodynamics as tools to elucidate the evolutionary processes and population dynamics that shape viral genetic diversity both at the inter-host (epidemics) and in intra-host level (individual infections).
Dr McCreesh is an Assistant Professor in Infectious Disease Modelling at the London School of Hygiene and Tropical Medicine.
She is interested in understanding Mtb transmission patterns, and in how contact data can be used to develop a better understanding of potential M.tb. transmission sites, and to inform intervention strategies. She also works on the calibration and analysis of complex individual-based stochastic models, and is involved with a project to develop a history matching and model emulation R package.
Previous research includes HIV and schistosomiasis modelling, and work on respondent-driven sampling.
MD, University of Athens, Greece
PhD, Syracuse University, NY
Chief of the Human Retrovirus Section of the National Cancer Institute, USA
Interests: HIV pathogenesis, Molecular Biology, gene regulation, Biotechnology, protein engineering, cytokines, Immunotherapy, Vaccines, Nucleic acid vaccines, gene therapy
I completed my Ph.D dissertation at the University of Zurich, Switzerland where the major focus of my PhD research project was the study of endogenous feline leukemia virus (enFeLV) in cats during exogenous feline leukemia virus (FeLV) infection. My interest in retroviruses led me into the HIV research after Ph.D. My postdoctoral research project at University of California, San Francisco was on HIV immunology. On completion of my Post Doc, I joined Dr Ndhlovu’s new laboratory at the University of Hawaii to pursue studies on HIV and Aging based on my expertise and experience to address a new area of HIV research in which have interest.
Currently my research work as an Assistant Professor at JNU, New Delhi, India is focused on aging in HIV-1-infected people. Approximately one in five individuals living with HIV infection in the United States is 50 years of age or older. This proportion continues to increase as HIV incidence remains stable and potent antiretroviral therapy has reduced the morbidity and mortality associated with HIV infection. However, premature aging and non-AIDS related morbidity including cancer seem to be a new big problem in HAART era. Chronic inflammation in treated HIV-1-infected subjects seems to play an important role in non-AIDS –related complications. The main goal of my research is to investigate the mechanism of HIV mediated accelerated aging/inflammation in HAART-suppressed HIV-1 infected people.
Dr. Gizachew Tessema is a perinatal and reproductive epidemiologist and health care services researcher with research interest that employed advanced statistical analyses, mixed methods research (MMR), and qualitative study. He is currently based at the Curtin School of Population Health, Curtin University.
Associate Professor Truc Thanh Thai has a background in public health and a PhD in health sciences from the University of Sydney, Australia. He has been working in the field of Biostatistics, Epidemiology and Research Methodology and is the Head of Department of Medical Statistics and Informatics at Faculty of Public Health, University of Medicine and Pharmacy at Ho Chi Minh City, Vietnam. Dr. Thai has been proactively working with researchers worldwide to address practical, public health issues. His research interests include Biostatistics, Data sciences, Artificial intelligence, Epidemiology, Mental health, Adolescent health, and quality of life in people with chronic diseases, HIV/AIDS, and Substance use.
After performing her PhD thesis at the National Institutes of Health (NIH, Bethesda, USA) from 1991 to 1994 and a postdoctoral fellowship in New York from 1994 to 1997, Carine Van Lint joined the Faculty of Sciences of the "Université Libre de Bruxelles" as the head of the Laboratory of Molecular Virology. As a biochemist, Carine Van Lint has developed for the last 25 years a specific interest for pathogenic retroviruses. Her laboratory is mainly studying the role played by epigenetic modifications (such as histone acetylation, histone methylation and DNA methylation) and by non-epigenetic regulatory elements in transcriptional latency and reactivation of HIV-1 (Human Immunodeficiency Virus type 1 - the ethiologic agent of the acquired immunodeficiency syndrome (AIDS)), BLV (Bovine Leukemia Virus - the etiologic agent of a chronic lymphoproliferative disease termed enzootic bovine leucosis) and HTLV-1 (Human T-cell leukemia virus 1 - the etiologic agent of an aggressive lymphoproliferative disease (Adult T-cell Leukemia/Lymphoma) and a neurological degenerative syndrome (tropical spastic paraparesis/HTLV-1-associated myelopathy (TSP/HAM)).
Chief, Laboratory for Virus Safety, Division of Biological Chemistry & Biologicals, National Institute of Health Sciences